Biohaven Ltd [BHVN] stock is trading at $11.84, up 6.57%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHVN shares have gain 19.23% over the last week, with a monthly amount glided 11.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on December 03, 2025, when H.C. Wainwright downgraded its rating to a Neutral but kept the price target unchanged to $11 for it. Previously, UBS downgraded its rating to Neutral on November 26, 2025, and kept the price target unchanged to $11. On November 06, 2025, downgrade downgraded it’s rating to Mkt Perform but maintained its price target of $9 on the stock. BofA Securities downgraded its rating to a Neutral but stick to its price target of $10 on November 05, 2025. Citigroup initiated its recommendation with a Buy and recommended $28 as its price target on September 17, 2025. Raymond James started tracking with a Strong Buy rating for this stock on September 03, 2025, and assigned it a price target of $75. In a note dated May 19, 2025, RBC Capital Mkts downgraded an Sector Perform rating on this stock but restated the target price of $21.
Biohaven Ltd [BHVN] stock has fluctuated between $7.48 and $44.28 over the past year. Currently, Wall Street analysts expect the stock to reach $22.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $11.84 at the most recent close of the market. An investor can expect a potential return of 90.03% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.91, Equity is -3.9 and Total Capital is -2.68. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-18.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Biohaven Ltd’s Current Ratio is 2.86. As well, the Quick Ratio is 2.86, while the Cash Ratio is 1.64.
Transactions by insiders
Recent insider trading involved Clark George C., VP, Chief Accounting Officer, that happened on Nov 17 ’25 when 17000.0 shares were purchased. Director, Bailey Gregory completed a deal on Nov 13 ’25 to buy 0.4 million shares. Meanwhile, Director CHILDS JOHN W bought 3.33 million shares on Nov 13 ’25.
